S
Sensus Healthcare Inc (SRTS)
Official siteHEALTHCARE • MEDICAL DEVICES • NASDAQ
$2.34
+0.02 (+0.65%)
Market Cap: $38.27M
Last updated: Nov 17, 2026 at 11:05 AM ET
Sensus Healthcare Inc (SRTS) Valuation Multiples
Sensus Healthcare (SRTS) trades at 2.3x sales and 1.1x book value. Its P/S of 2.3x is below its 5-year median of 2.5x. Its forward P/E is 21.4x.
Current Multiples
| Multiple | Value |
|---|---|
| P/E (trailing) | N/A |
| Forward P/E | 21.4x |
| Price to sales | 2.3x |
| Price to book | 1.1x |
| PEG | N/A |
| FCF yield | -29.9% |
Historical Medians
Against its 10-year medians, its P/S is 25.8% below 3.1x and its P/B is 59.3% below 2.7x.
| Multiple | Current | 5-year median | 10-year median |
|---|---|---|---|
| P/S | 2.3x | 2.5x | 3.1x |
| P/B | 1.1x | 1.5x | 2.7x |
Valuation History
Over the 4 of the 10 year ends shown that have a P/E, its P/E ranged from 5.1x in 2022 to 78.7x in 2023.
| Year end | Price | P/E | P/S | P/B |
|---|---|---|---|---|
| 2025 | $3.98 | N/A | 2.4x | 1.4x |
| 2024 | $6.92 | 17.3x | 2.7x | 2.0x |
| 2023 | $2.36 | 78.7x | 1.6x | 0.8x |
| 2022 | $7.42 | 5.1x | 2.8x | 2.6x |
| 2021 | $7.22 | 30.1x | 4.4x | 4.6x |
| 2020 | $3.86 | N/A | 6.6x | 3.0x |
| 2019 | $3.54 | N/A | 2.1x | 2.0x |
| 2018 | $7.41 | N/A | 4.0x | 4.5x |
| 2017 | $5.16 | N/A | 3.3x | 5.9x |
| 2016 | $5.25 | N/A | 4.4x | 4.7x |
GNG Valuation
| GNG view | Undervalued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About SRTS
What is SRTS's forward P/E ratio?
Sensus Healthcare has a forward P/E ratio of 21.4x.
Is SRTS stock overvalued?
GNG's valuation label for SRTS is Undervalued.
What is SRTS's price to sales ratio?
Sensus Healthcare has a price to sales ratio of 2.3x.
SRTS pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors